Dr. Ken Wong, who joined KGI in August 2014, is currently Director of Health Economics and Outcomes Research at Novartis Pharmaceuticals. He has been in the healthcare industry for over 30 years in various leadership positions. Prior to joining the pharmaceutical industry, Dr. Wong led clinical departments at health insurance plans, home healthcare, and physician practice management company. He has served as an Accreditation Surveyor at the Joint Commission where he surveyed and advised healthcare systems on pharmaceutical standards of quality and care. Dr. Wong was previously on faculty as a Professor of Practice at the Keck Graduate Institute, School of Pharmacy.
Dr. Wong holds a Doctorate in Pharmacy from the University of Southern California and a Masters in Public Health from the University of Massachusetts at Amherst.
Wong KS, Boulanger L, Smalarz A, Wu N, Fraser K, Wogen J. “Impact of care management processes and integration of care on blood pressure control in diabetes.” BMC Family Practice Journal. 2013; 14:30
Snider J, Romley J, Wong KS, Zhang J, Eber M, Goldman D. “The Disability Burden of COPD.” COPD: Journal of Chronic Obstructive Pulmonary Disease. 2012; 9(5): 513-521.
Wong KS, Smalarz A, Wu N, Boulanger, L, Wogen J. “The association between hypertension-specific care management processes and blood pressure outcomes in US-based physician organizations,” Journal of American Society of Hypertension. 2011;5(6):505-512.
Taira DA, Wong KS, Frech-Tamas F, and Chung RS, “Copayment Level and Compliance with Antihypertensive Medication: Analysis and Policy Implications for Managed Care,” American Journal of Managed Care. 2006; 12:678-683.